4
Changes in Ownership
Lexaria Bioscience Corp. Filed Acc 0001103780-17-000002
CEO acquired 29,475 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| BUNKA CHRISTOPHER CEO | 2017-12-01 | Grant or award | +29,475 | $0.82 | $24,170 | 7,265,054 | D: show line 1 in the form |
Loading xslF345X03/primary_doc.xml…